Top Markets
Coin of the day
Medigene AG Medigene AG

Medigene AG

MDG1
주식 순위 #35468
Medigene AG is a German biotechnology company primarily focused on innovating T... Medigene AG is a German biotechnology company primarily focused on innovating T cell immunotherapies to treat various cancers. Their developmental pipeline includes personalized T cell therapies, particularly T cell receptor-modified T cells, which are progressing through clinical stages to tackle significant unmet medical requirements. Additionally, the firm researches dendritic cell vaccines and T cell-specific monoclonal antibodies. Outside of its oncology efforts, Medigene is actively engaged in developing and bringing to market RhuDex for uses within hepatology and gastroenterology. A key strategic alliance exists with 2seventy bio, Inc., centered on advancing T cell receptors. The company also maintains research collaborations with the Université de Montréal and Cytovant Sciences Co. Ltd., investigating new cancer antigens for immunotherapy applications. Medigene's global presence encompasses operations across Europe, the United States, Asia, and various other international territories. Founded in 1994, the company's headquarters are located in Munich, Germany.
주가
$0.14942078
마지막 동기화: 2025-05-15
시가총액
$3.86M
변동 (1일)
0.10%
변동 (1년)
0.00%
국가
DE
거래 Medigene AG (MDG1)

카테고리

Medigene AG (MDG1)의 주가 이력
최고 종가: $0.15 (2025-05-01 기준)

최저 종가: $485.97 (2000-06-01 기준)
Medigene AG의 주가 이력 (2000 ~ 2026)
연간 주가 성과
연도 성과
2025 -86.77%
2024 -62.95%
2023 -30.06%
2022 -29.39%
2021 -24.90%
2020 -16.27%
2019 -42.37%
2018 -38.37%
2017 36.28%
2016 46.54%
2015 44.80%
2014 3.96%
2013 -9.91%
2012 0.94%
2011 -50.52%
2010 -49.02%
2009 6.35%
2008 -36.07%
2007 -14.51%
2006 -12.21%
2005 -5.50%
2004 40.71%
2003 93.97%
2002 -80.04%
2001 -73.85%
2000 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE